First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
The first half of 2020 has been unprecedented. There has been some good, a lot of bad and even some ugly.
San Diego, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
With a continued focus on the harmful effects of the opioid epidemic, oversight of opioid prescribing and monitoring of use t
San Diego, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
2019 yielded another year of declines in both opioid utilization and cost.